Does fluid hysteroscopy increase the stage or worsen the prognosis in patients with endometrial cancer? a randomized controlled trial

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 115, Issue 2, 2004, Pages 211-215

  Sáinz De La Cuesta, Ricardo ^a   Angel Espinosa, Jose ^a   Crespo, Ernesto ^a   José Granizo, Juan ^b   Rivas, Francisca ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Madrid Hospital   (Spain)

Author keywords

Endometrial cancer; Fluid hysteroscopy; Prognosis

Indexed keywords

ADULT; AGED; ANESTHESIA; ARTICLE; CANCER STAGING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; ENDOMETRIUM BIOPSY; ENDOMETRIUM CANCER; FEMALE; FLUID HYSTERESCOPY; FOLLOW UP; HUMAN; HYSTEROSCOPY; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; PARAAORTIC LYMPH NODE; PELVIS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 3242682412     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2004.01.029     Document Type: Article

References (37)

1. Jemal A., Thomas A., Murray T., Thun M. Cancer statistics. CA Cancer J. Clin. 52:2002;23-47
2. Towsend D.E., Fields G., Mc Causland A., Kauffman K. Diagnostic and operative hysteroscopy in the management of persistent postmenopausal bleeding. Obstet. Gynecol. 82:1993;419-421
3. Cicinell E., Comi N., Scorcia P., Petruzzi D., Epifani S. Hysterocopy for diagnosis and treatment of endometrial adenocarcinoma precursors: a review of the literature. Eur J. Gynaecol. Oncol. 15:1994;115-118
4. Gimpelson R.J., Rappold H.O. A comparative study between panoramic hysteroscopy with directed biopsies and dilatation and curettage. A review of 276 cases. Am. J. Obstet. Gynecol. 158:1988;489-492
5. Loffer F.D. Hysteroscopy with selective endometrial sampling compared with D and C for abnormal uterine bleeding: the value of negative hysteroscopic view. Obstet. Gynecol. 73:1989;16-20
6. Ben-Yehuda O.M., Kim Y.B., Leuchter R.S. Does hysteroscopy improve upon the sensitivity of dilation and curettage in the diagnosis of endometrial hyperplasia or carcinoma? Gynecol. Oncol. 68:1998;4-7
7. Romano S., Shimoni Y., Muralee D., Shalev E. Retrograde seeding of endometrial cancer during hysteroscopy. Gynecol. Oncol. 44:1992;116-118
8. Schmitz M.J., Nahhas W.A. Hysteroscopy may transport malignant cells into the peritoneal cavity. Case report. Eur. J. Gynaecol. Oncol. 15:1994;121-124
9. Egarter C., Krestan C., Kurz C. Abdominal dissemination of malignant cells with hysteroscopy. Gynecol. Oncol. 63:1996;143-144
10. Workman R.D., Wong D.S., Pitts W.C. Embolic vascular seeding of endometrial adenocarcinoma, a complication of hysteroscopic endometrial biopsy. Gynecol. Oncol. 72:1999;261-264
11. Announcements. FIGO stages: 1988 revision. Gynecol Oncol 1989;35:125-6.
12. Zuna R.E., Behrens A. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients. J. Natl. Cancer Inst. 88:1996;980-987
13. Morrow C.P., Bundy B.N., Kurman K.J., Creasman W.T., Heller P., Homesley H.D., et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a gynecologic oncology group study. Gynecol. Oncol. 40:1991;55-65
14. International Federation of Gynecology and Obstetrics. Annual Report on the results of treatment in gynecologic cancer. Int J Gynecol Obstet 1989;28:189-90.
15. Armitage P. Statistical Methods in Medical Research. New York: Wiley, 1971.
16. Fisher R.A. On the mathematical foundation of theoretical statistics. Philos. Trans. R. Soc. London A. 222:1922;309-368
17. Creasman W., Odicino F., Maisonneuve P., Benedet J., Shepherd J., Sideri M., et al. Carcinoma of the corpus uteri. Annual report on the results of treatment in gynaecological cancer. J Epidemiol. Biostat. 3:1998;35-61
18. Creasman W.T., Rutledge F. The prognostic value of peritoneal cytology in gynecologic malignant disease. Am. J. Obstet. Gynecol. 110:1971;773-781
19. Creasman W.T., Disai P.J., Blessing J., Wilkinson R.H. Jr., Johnston W., Weed J.C. Jr. Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticals. Am. J. Obstet. Gynecol. 141:1981;921-927
20. Mazurka J.L., Drepart G.V., Lotocki R.J. Prognostic significance of positive peritoneal cyotology in endometrial carcinoma. Am. J. Obstet. Gynecol. 158:1988;303-306
21. Harouny V.R., Sutton G.P., Clark S.A., Geisher H.E., Stehman F.B., Ehrlich C.E. The importance of peritoneal cytology in endometrial carcinoma. Obstet. Gynecol. 72:1988;394-398
22. Turner D.A., Gershenson D.M., Atkinson N., Sneige N., Wharton J.T. The prognostic significance of peritoneal cytology for stage I endometrial cancer. Obstet. Gynecol. 74:1989;775-779
23. Lurain J.R., Rice B.L., Rademaker A.W., Poggensee L.E., Schink J.C., Miller D.S. Prognostic factors associated with recurrence in clinical stage I adenocarcinoma of the endometrium. Obstet. Gynecol. 78:1991;63-69
24. Lurain J.R., Rumsey N.K., Schink J.C., Wallermar C.B., Chmiel J.S. Prognostic significance of positive peritoneal cytology in clinical stage I adenocarcinoma of the endometrium. Obstet. Gynecol. 74:1989;175-179
25. Grimshaw R.N., Tupper W.C., Fraser R.C., Tompkins M.G., Jeffrey J.F. Prognostic value of peritoneal cyotology in endometrial cancer. Gynecol. Oncol. 36:1990;97-100
26. Kouski A., Poulter C., Keys H., Rubin P., Beecham J., Doane K. Absence of prognostic significance, peritoneal dissemination and treatment advantage in endometrial cancer patients with positive peritoneal cytology. Int. J. Radiat. Oncol. Biol. Phys. 4:1988;49-55
27. Yazigi R., Piver M.S., Blomenson L. Malignant peritoneal cytology as prognostic indicator in stage I endometrial cancer. Obstet. Gynecol. 62:1983;359-362
28. Kennedy A.W., Paterson G.L., Becker S.N., Nuñez C., Webster K.D. Experience with pelvic washings in stage I and II endometrial carcinoma. Gynecol. Oncol. 28:1987;50-60
29. Imachi J., Tsukamoto N., Matsuyama T., Nakano H. Peritoneal cytology in patients with endometrial carcinoma. Gynecol. Oncol. 30:1988;76-86
30. Kadar N., Homesley H.D., Malfetano J.H. Positive peritoneal cytology is an adverse factor in endometrial in endometrial carcinoma only if there is evidence of extrauterine disease. Gynecol. Oncol. 46:1992;145-149
31. Sagawa T., Yamada H., Sakuragi N., Fugimoto S. A comparison between preoperative and operative findings of peritoneal cytology in patients with endometrial cancer. Asia Oceania J. Obstet. Gynaecol. 20:1994;39-47
32. Levêque J., Goyat F., Dugast J., Loeillet L., Grall J.Y., Le-Bars S. Value of cytology after hysteroscopy in surgical stage I adenocarcinoma of the endometrium. Oncol. Rep. 5:1998;713-715
33. Obermair A., Geramon M., Gocer F., Denison U., Graf A.H., Kapshammer E., et al. Does hysteroscopy facilitate tumor cell dissemination? Incidence of peritoneal cytology from patients with early stage endometrial carcinoma following dilatation and curettage (D and C) versus hysteroscopy and D and C. Cancer. 88:2000;139-143
34. Gücer F., Tamussino K., Reich O., Moser F., Arikan G., Winter R. Two-year follow-up of patients with endometrial carcinoma after preoperative fluid hysteroscopy. Int. J. Gynecol. Cancer. 8:1998;476-480
35. Arikan G., Reich O., Weiss U., Hahn T., Reinisch S., Tamussino K., et al. Are endometrial carcinoma cells disseminated at hysteroscopy functionally viable. Gynecol. Oncol. 83:2001;221-226
36. Owen G., Duncan I.D. Is there any value in the long term follow-up of women treated for endometrial cancer? Br. J. Obstet. Gynaecol. 104:1997;710-713
37. Salvesen H.B., Akslen L.A., Iversen T., Iversen D.E. Recurrence of endometrial carcinoma and the value of routine follow-up. Br. J. Obstet. Gynaecol. 104:1997;1302-1307